7 completed, 4 recruiting, 1 active not recruiting, 1 unknown. 4 Phase 1, 4 Phase 3, 3 Not applicable, 3 Phase 2, 2 Phase 4.
Follow Placebo (Saline Solution): new trials by email Literature Review of Placebo (Saline Solution) trials Research Report on Placebo (Saline Solution)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Analgesic Efficacy and Obstetric Effects of Tramadol, Paracetamol and Placebo in Active Labor Tramadol Hydrochloride, Paracetamol (acetaminophen), Placebo (Saline Solution) - Labor Pain | Phase 4 | Recruiting | Universidad Nacional Autonoma de Honduras | 300 | 2026-02-15 | 2026-02-27 |
| Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell) Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell), Placebo (Saline solution) - Respiratory Syncytial Virus (RSV) | Phase 3 | Recruiting | MAXVAX Biotechnology Limited Liability Company | 25000 | 2025-10-22 | 2025-12-09 |
| Safety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and Above Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells)(low dose), Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells)(high dose), Placebo (Saline solution) - Respiratory Syncytial Virus (RSV) | Phase 1 / Phase 2 | Active not recruiting | MAXVAX Biotechnology Limited Liability Company | 522 | 2024-11-13 | 2025-06-06 |
| A Study on the Immune Response, Safety and the Occurrence of Respiratory Syncytial Virus (RSV)-Associated Respiratory Tract Illness After Administration of RSV OA Vaccine in Adults 60 Years and Older RSVPreF3 OA investigational vaccine, Placebo (Saline solution) - Respiratory Syncytial Virus Infections | Phase 3 | Completed | GlaxoSmithKline | 2620 | 2024-08-05 | 2026-05-19 |
| Leukocyte-rich PRP or Leukocyte-free PRP vs Placebo in the Treatment of Epicondylitis Injection of autologous leukocyte rich platelet rich plasma (LR-PRP), Injection of autologous leukocyte poor platelet rich plasma (LP-PRP), Placebo (saline solution) - Tennis Elbow | Not applicable | Recruiting | Istituto Ortopedico Rizzoli | 240 | 2023-03-23 | 2025-09-29 |
| Post-surgical Scars After the Use of CACIPLIQ20 CACIPLIQ20®, Placebo (saline solution) - Scars | Phase 3 | Unknown | Organ, Tissue, Regeneration, Repair and Replacement | 50 | 2023-03-21 | 2024-02-13 |
| Hydrolyzed Collagen Formulation vs Placebo in Knee Osteoarthritis Collagen, Placebo (saline solution) - Knee Osteoarthritis | Not applicable | Recruiting | Istituto Ortopedico Rizzoli | 204 | 2022-02-16 | 2026-02-03 |
| A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults Pentamer (low)/gB(low)/Adjuvant vaccine, Pentamer (med)/gB(low)/Adjuvant vaccine, Pentamer (med)/gB(med)/Adjuvant vaccine - Cytomegalovirus Infections | Phase 1 / Phase 2 | Completed | GlaxoSmithKline | 333 | 2021-10-14 | 2026-07-17 |
| A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults RSV Vaccine (GSK3844766A) unadjuvanted low dose, RSV Vaccine (GSK3844766A) low dose adjuvanted with AS01E, RSV Vaccine (GSK3844766A) low dose adjuvanted with AS01B - Respiratory Syncytial Virus Infections | Phase 1 / Phase 2 | Completed | GlaxoSmithKline | 1053 | 2019-01-21 | 2022-08-05 |
| Steroid Use in Pediatric Fluid and Vasoactive Infusion Dependent Shock - Pilot Study Hydrocortisone, Placebo - Shock | Phase 4 | Completed | Children's Hospital of Eastern Ontario | 57 | 2014-07-01 | 2019-03-26 |
| A Study to Assess the Effects of 2 Prothrombin Complex Concentrates on the Pharmacodynamics of Apixaban in Healthy Adult Subjects Apixaban, Cofact (4-Factor PCC), Beriplex P/N (4-Factor PCC) - Anticoagulation | Phase 1 | Completed | Bristol-Myers Squibb | 43 | 2014-02-01 | 2015-08-13 |
| GnRH Antagonist for Treatment of Early Ovarian Hyperstimulation Syndrome GnRH antagonist (Cetrorelix), Placebo (saline solution) - Ovarian Hyperstimulation Syndrome, Effects of Gonadotropin | Phase 3 | Completed | Instituto Valenciano de Infertilidad, IVI VALENCIA | 100 | 2012-04-01 | 2013-09-19 |
| Prevention of Neurosurgical Wound Infections Vancomycin, Placebo (Saline Solution) - Surgical Wound Infections | Not applicable | Completed | Oregon Health and Science University | 214 | 2009-05-13 | 2019-04-30 |
Respiratory Syncytial Virus Infections (2) · Adrenal Insufficiency (1) · Cicatrix (1) · Cytomegalovirus Infections (1) · Infections (1) · Labor Pain (1) · Osteoarthritis (1) · Osteoarthritis, Knee (1) · Ovarian Hyperstimulation Syndrome (1) · Shock (1) · Surgical Wound Infection (1) · Tennis Elbow (1)
GlaxoSmithKline (3) · Istituto Ortopedico Rizzoli (2) · MAXVAX Biotechnology Limited Liability Company (2) · Bristol-Myers Squibb (1) · Children's Hospital of Eastern Ontario (1) · Instituto Valenciano de Infertilidad, IVI VALENCIA (1) · Oregon Health and Science University (1) · Organ, Tissue, Regeneration, Repair and Replacement (1) · Universidad Nacional Autonoma de Honduras (1)
China (3) · United States (3) · Italy (2) · Spain (2) · Belgium (1) · Canada (1) · Finland (1) · France (1) · Honduras (1) · Japan (1) · Poland (1) · South Korea (1) · United Kingdom (1)
Alessandro Di Martino, MD (1) · Enrico Guerra, MD (1) · Gilbert Zakine (1) · Hector Wong, MD (1) · James D McNally, MD, PhD (1) · Juan Giles, MD (1) · Karen Choong, MB, MSc (1) · Kim J Burchiel, MD (1) · Kusum Menon, MD, MSc (1) · Lauralyn McIntyre, MD, MSc (1) · Lili Huang (1) · Margaret Lawson, MD, MSc (1) · Stephen T Magill, PhD (1)
PMID 27153945, PMID 35904987, PMID 38503664
2018 (1), 2023 (1)